23rd December, 2002
Ministry of Law & Justice  


INDIA UPGRADES LEGAL SYSTEM FOR PATENT RELATED LITIGATION


India has upgraded its legal system to handle patent related litigation and to allow patent in all areas of technology. Accordingly, the provisions relating to the setting up of the Intellectual Property Appellate Board (Tribunal) contained in the Trade Marks Act, 1999, with suitable modifications, have been made applicable to the Patent Law by the Patents (Amendment) Act, 2002. This is intended to ensure speedy disposal of appeals against the decisions of the Controller of Patents, which at present lie to the High Court. The Act provides for appointment of Technical Member having experience in patents. The Patent Act, 1970, as amended by the Patents (Amendment) Act, 2002 has, thus, fulfilled India’s international obligations contained in the Trade Related Intellectual Property Rights (TRIPS) Agreements of World Trade Organisation (WTO) Agreement.

The process of setting up IP Appellate Board, with its headquarters at Chennai, has already been set in motion. Doha Ministerial Declaration has provided a mandate to address the issue of relationship between the TRIPS Agreement and the bio-diversity and protection of traditional knowledge and folklore as outstanding implementation issues. Besides, Doha Declaration on the TRIPS Agreement and Public Health provides for exemption to Less Developed Countries (LDCs) till January 1, 2016 for implementing or applying the provisions of Section 5 (Patents) and Section 7 (Protection of Undisclosed Information).

Doha Declaration on the TRIPS Agreement on Public Health affirms that the TRIPS Agreement can and should be interpreted to protect public health and promote access to medicines for all. The Declaration recognizes the affordability and availability of medicines as a universal right.

The Ministers at Doha agreed that the TRIPS Agreement does and should not prevent members from taking measures to protect public health. The Declaration reaffirms the Members’ right to use, to the full, the flexibility of compulsory license and parallel import for public health. It clarifies that the Governments have freedom to determine the grounds to grant compulsory licenses. The Declaration also clarifies that each Member nation has the right to determine what constitutes a national emergency or other circumstances of extreme urgency for issuing compulsory licenses on expeditious basis. The Declaration also clarifies that each Member nation is free to establish its own regime for exhaustion of IPRs (parallel import).

 

 
[previous release] [next release]